Modulation of fluid-phase complement activation inhibits hyperacute rejection in a porcine-to-human xenograft model

Transplant Proc. 2000 Aug;32(5):899-900. doi: 10.1016/s0041-1345(00)01028-9.

Authors

A E Fiane¹, V Videm, J D Lambris, O R Geiran, J L Svennevig, T E Mollnes

Affiliation

¹ The National Hospital, University of Oslo, Oslo, Norway.

PMID: 10936264
DOI: 10.1016/s0041-1345(00)01028-9

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Animals
Blood Transfusion*
Complement Activation / physiology*
Graft Rejection / immunology
Graft Rejection / prevention & control*
Graft Survival / drug effects
Graft Survival / immunology*
Humans
Immunoglobulins, Intravenous / pharmacology*
Swine
Transplantation, Heterologous / immunology*

Substances

Immunoglobulins, Intravenous